150 related articles for article (PubMed ID: 3218975)
1. Antitumour activity of a new water-soluble nitrosoureido sugar: CY233 (NSC 609224).
Gosse C; Atassi G; Letourneux Y; Ardouin P; Gouyette A; Fournier JP; Roger P
Anticancer Res; 1988; 8(6):1419-22. PubMed ID: 3218975
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumour activity of several new 4-aroyl-1-nitrosohydrazinecarboxamides.
Gugova R; Topakbashian V; Lozeva S; Dimov S; Golovinsky E
Drugs Exp Clin Res; 1997; 23(2):71-5. PubMed ID: 9309382
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic and diabetogenic potential of two newly synthesized nitrosoureido sugars.
Bernacki RJ; Wilson GL; Mossman BT; Angelino N; Kanter PM; Korytnyk W
Cancer Res; 1985 Feb; 45(2):695-702. PubMed ID: 3881170
[TBL] [Abstract][Full Text] [Related]
4. The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals.
Imbach JL; Montero JL; Moruzzi A; Serrou B; Chenu E; Hayat M; Mathe G
Biomedicine; 1975 Dec; 23(10):410-3. PubMed ID: 1222217
[TBL] [Abstract][Full Text] [Related]
5. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Fox PA; Panasci LC; Schein PS
Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and preclinical toxicological studies of 1,2-diaminocyclohexane(isocitrato)platinum(II).
Macquet JP; Cros S; Armand JP
Cancer Res; 1984 Sep; 44(9):3736-43. PubMed ID: 6540142
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumour activity of a new series of nitrosoureido sugars.
Monneret C; Rissé S; Ardouin P; Gouyette A
Eur J Med Chem; 2000 Jan; 35(1):137-46. PubMed ID: 10733610
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of the novel nitrosourea S10036 in rodent tumors.
Filippeschi S; Colombo T; Bassani D; De Francesco L; Arioli P; D'Incalci M; Bartosek I; Guaitani A
Anticancer Res; 1988; 8(6):1351-4. PubMed ID: 3064716
[TBL] [Abstract][Full Text] [Related]
9. Formulation of three nitrosoureas for intravenous use.
Davignon JP; Yang KW; Wood HB; Cradock JC
Cancer Chemother Rep 3; 1973 May; 4(3):7-11. PubMed ID: 4201309
[No Abstract] [Full Text] [Related]
10. Hypothetical mechanism of therapeutic synergism induced by the combination of 6-thioguanine and 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M; Sakurai Y
Cancer Res; 1982 Oct; 42(10):4079-85. PubMed ID: 6955008
[No Abstract] [Full Text] [Related]
11. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
Brundrett RB; Colvin M; White EH; McKee J; Hartman PE; Brown DL
Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumour activity of 4-nitroso-4-(2-chloroethyl)semicarbazides.
Gugova RG; Raikov ZD; Zakhariev SG; Demirov GD; Todorov DK; Ilarionova MV
Drugs Exp Clin Res; 1989; 15(10):497-500. PubMed ID: 2632217
[TBL] [Abstract][Full Text] [Related]
13. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new nitrosoureido water-soluble sugar, ecomustine or CY 233 (NSC 609224), on human xenografts.
Dumont P; Atassi G; Roger P
In Vivo; 1990; 4(1):61-4. PubMed ID: 2103843
[TBL] [Abstract][Full Text] [Related]
15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.
Akaike Y; Arai Y; Taguchi H; Satoh H
Gan; 1982 Jun; 73(3):480-7. PubMed ID: 7129012
[TBL] [Abstract][Full Text] [Related]
17. [Action of nitrosoalkylureas and the longevity of tumor-bearing animals].
Krutova TV; Kondradov AA; Ostrovskaia LA
Izv Akad Nauk SSSR Biol; 1983; (6):843-50. PubMed ID: 6655115
[No Abstract] [Full Text] [Related]
18. Biological activity of hydroxylated chloroethylnitrosoureas.
Zeller WJ; Frühauf S; Chen G; Eisenbrand G; Lijinsky W
Cancer Res; 1989 Jun; 49(12):3267-70. PubMed ID: 2720679
[TBL] [Abstract][Full Text] [Related]
19. O6-methylguanine and temozolomide can reverse the resistance to chloroethylnitrosoureas of a mouse L1210 leukemia.
D'Incalci M; Taverna P; Erba E; Filippeschi S; Potenza D; Mariani L; Citti L; Catapano CV
Anticancer Res; 1991; 11(1):115-21. PubMed ID: 2018345
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.
Schein PS; Panasci L; Woolley PV; Anderson T
Cancer Treat Rep; 1976 Jun; 60(6):801-5. PubMed ID: 133756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
